Contract award for base IDIQ. Title: pharmacokinetic analysis resource center. The contractor will provide support to clinical pharmacology/pharmacokinetic studies including interaction studies. The…
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N95025D00007
- Awardee
-
Technical Resources International, Inc. UEI FAA2LVENETH4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Task orders
- 4 $546,347 obligated
Award facts
- Combined order value
- $546,347 Current and potential, with all options
- Last date to order 29% complete
- IDV ceiling 22% used
- $2,500,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute on Drug Abuse awarded a single-award indefinite-delivery contract to Technical Resources International, Inc., a minority-owned, woman-owned, Hispanic American-owned small business, with a ceiling of $2.5 million and an award date of May 15, 2025. The contract runs through May 14, 2030.
The contractor provides support to clinical pharmacology and pharmacokinetic studies, including interaction studies, protocol preparation, and clinical study monitoring. Performance takes place in Westlake, Maryland.
Four delivery orders have been issued under this IDIQ. The largest, Task Order 1, awards $487,769 for Phase I single ascending dose study support, with performance spanning May 15, 2025 through November 14, 2028, priced on a cost-plus-fixed-fee basis. Task Order 3 provides $36,099 for other pharmacokinetic analysis resource center support services through July 22, 2027. Task Order 2 covers Phase I clinical pharmacology and pharmacokinetic study support at $11,079, running through July 31, 2027. Task Order 4, issued June 5, 2026, awards $11,400 for Phase III protocol work (STP7) through March 4, 2027. All orders are cost-plus-fixed-fee and carry no set-aside restrictions.
Description
Contract award for base IDIQ. Title: pharmacokinetic analysis resource center. The contractor will provide support to clinical pharmacology/pharmacokinetic studies including interaction studies. The contractor shall also prepare protocols, and monito
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N95025D00007?
75N95025D00007 was awarded to Technical Resources International, Inc. by National Institute on Drug Abuse (National Institutes of Health) on May 15, 2025.
How much is contract 75N95025D00007 worth?
Orders under 75N95025D00007 have obligated $546,347. 75N95025D00007's own ceiling is $2,500,000.
How many orders have been placed under contract 75N95025D00007?
4 orders have been placed under 75N95025D00007, the latest on June 5, 2026.
Who can order from contract 75N95025D00007?
75N95025D00007 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N95025D00007 competed?
The extent of competition for 75N95025D00007 was full and open competition. The government received 2 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV